文献速递外周动脉疾病

腔内再通与自体静脉旁路治疗血栓闭塞性脉管炎合并胫腓动脉闭塞所致严重肢体缺血的结果比较

Outcomes of endovascular recanalization versus autogenous venous bypass for thromboangiitis obliterans patients with critical limb ischemia due to tibioperoneal arterial occlusion.
PubMed 文献 · J Vasc Surg · 2017-07-08

该单中心回顾性研究纳入75例血栓闭塞性脉管炎合并严重下肢缺血患者共90条肢体,比较腔内再通(ER组35例43条)与自体静脉旁路(AVB组40例47条)治疗胫腓动脉闭塞的效果。ER组即刻失败率及再干预率更高、3年通畅率更低,但1年和3年免截肢生存率与AVB组相似。坏疽是主要截肢的独立相关因素,活动性溃疡是原发通畅率较差的唯一风险因素。

要点

  • ER组即刻失败率在股腘段为36.36%、胫腓段为65.52%,均高于AVB组的14.89%。
  • ER组再干预率62.79%高于AVB组的27.66%,3年原发和二期通畅率均更低。
  • 两组1年及3年免截肢生存率相似,ER可作为不适合旁路患者的保肢策略。

核心结论

  • 对于不适合旁路的血栓闭塞性脉管炎患者,ER是可接受的保肢策略,免截肢生存率与AVB相当,但通畅率更低且再干预率更高。

研究设计与样本

  • 主要结局为随访期间免截肢生存率,次要结局包括通畅率、即刻失败、围手术期并发症和再干预率。

主要发现

  • ER组即刻失败率股腘段36.36%、胫腓段65.52%,AVB组14.89%(P=.03和<.001)。
  • ER组再干预率62.79% vs AVB组27.66%(P<.001)。
  • 3年原发通畅率ER组股腘段18.96%、胫腓段14.37%,AVB组60.41%(P=.008和<.001)。
  • 3年二期通畅率ER组股腘段33.85%、胫腓段21.29%,AVB组68.78%(P=.04和.002)。
  • 1年免截肢生存率ER组92.9% vs AVB组93.2%(P=.81),3年87.8% vs 90.6%(P=.66)。

关键数值与推荐

  • 坏疽是主要截肢的独立相关因素(HR 2.24,95%CI 1.33-4.3,P=.02)。
  • 活动性溃疡是随访期间原发通畅率较差的唯一风险因素(HR 1.86,95%CI 0.55-5.6,P=.04)。

临床怎么用

  • 对不适合旁路的血栓闭塞性脉管炎合并胫腓动脉闭塞患者,ER可作为保肢选择,但需预期更高的再干预率和更低的通畅率。
  • 存在坏疽的患者主要截肢风险更高,应加强监测与干预。

局限性

  • 回顾性单中心设计,样本量有限。
  • ER组并非所有患者均为旁路候选者,存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study sought to compare the outcomes of endovascular recanalization (ER) vs autogenous venous bypass (AVB) for tibioperoneal arterial occlusion in thromboangiitis obliterans patients with critical lower limb ischemia. METHODS: A total of 90 limbs in 75 patients, successfully treated with ER (ER group, 35 patients, 43 limbs) and AVB (AVB group, 40 patients, 47 limbs) for tibioperoneal arterial occlusions from January 2009 to December 2015 in a single institution, were retrospectively analyzed. The characteristics and outcomes were compared between the two groups. The primary outcome was the amputation-free survival rate during follow-up; the secondary outcomes were patency rates, immediate failure, periprocedural complications, and rates of reintervention. Univariate and multivariate analysis to identify potentially significant predictors of amputation-free survival and primary patency in the whole study group was performed. RESULTS: Not all patients in the ER group were bypass candidates because of unavailable runoff arteries or adequate conduit for bypass. Other baseline characteristics were similar between groups. Patients in the ER group had a much higher incidence of immediate failure (36.36% in femoropopliteal segment and 65.52% in tibioperoneal segment vs 14.89% in AVB bypass; P = .03 and < .001). Although patients in the ER group had a significantly higher rate of reintervention (62.79% vs 27.66%; P < .001) associated with a significantly lower primary patency rate (18.96% in femoropopliteal segment and 14.37% in tibioperoneal segment vs 60.41% in AVB bypass; P = .008 and < .001) and secondary patency rate (33.85% in femoropopliteal segment and 21.29% in tibioperoneal segment vs 68.78% in AVB bypass; P = .04 and .002) at 3 years, the amputation-free survival in the ER group and AVB group was similar at 1 year (92.9% vs 93.2%; P = .81) and 3 years (87.8% and 90.6%; P = .66). Univariate and multivariate analysis showed that the presence of gangrene was independently associated with major amputation (hazard ratio, 2.24; 95% confidence interval, 1.33-4.3; P = .02); however, the presence of active ulcer was the only risk factor for poorer primary patency during follow-up (hazard ratio, 1.86; 95% confidence interval, 0.55-5.6; P = .04). CONCLUSIONS: ER is a valid strategy for limb salvage in thromboangiitis obliterans patients who are unsuitable for bypass, contributing an acceptable amputation-free survival as high as with AVB, even though it is associated with lower patency rates and a higher rate of reintervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ye K, Shi H, Qin J, et al. Outcomes of endovascular recanalization versus autogenous venous bypass for thromboangiitis obliterans patients with critical limb ischemia due to tibioperoneal arterial occlusion. J Vasc Surg. 2017. PMID: 28697938. doi:10.1016/j.jvs.2017.03.425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。